This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...

Eisai and Biogen’s marketing application for Alzheimer’s disease therapy Leqembi will face an independent advisory committee convened by the EMA before a decision is made on approval.

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

Members of the media raise their hands as White House Press Secretary Karoline Leavitt delivers remarks during her first daily briefing, at the White House, in Washington, U.S. January 28, 2025 ...